Hydrochlorothiazide

Product NDC
51079-776
Requested package NDC
51079-776-20
11-digit product format
510790776
Labeler code
51079
Product ID
51079-776_a59f8988-f146-7db2-e053-2995a90aa70f
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
hydrochlorothiazide
Dosage form
CAPSULE
Route
ORAL
Labeler
Mylan Institutional Inc.
Application
ANDA075640
Marketing category
ANDA
Marketing start
2005-11-01
Marketing end
2021-06-30
Substance
HYDROCHLOROTHIAZIDE
Active strength
13 mg/1
Pharmacologic classes
Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage51079-77651079-776-20DDiscontinued by firm2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A075640-001HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-28011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-2831067a03dcf5…
2025-08-23 18:47 UTC2025-08A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-286a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-28fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-28b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-2803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-282680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-285bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-28d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-28d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-2879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-28301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-281e350fbaab3a…
2024-05-31 18:47 UTC2024-05A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-288072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORALAB2000-01-285c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORALAB2000-01-285d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORALAB2000-01-284b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORALAB2000-01-2874a2ff9319b5…
2022-03-09 01:35 UTC2022-03A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORALAB2000-01-28bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORALAB2000-01-28782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORALAB2000-01-2887673890dc5c…
2021-03-12 10:30 UTC2021-03A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORALAB2000-01-285aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORALAB2000-01-288869cabd3fbd…
2020-11-12 02:37 UTC2020-11A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORALAB2000-01-28c0c555d07b60…
2019-12-14 00:12 UTC2019-12A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORALAB2000-01-283f01610625f2…
2019-09-15 20:21 UTC2019-09A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORALAB2000-01-28b00525d2431f…
2019-07-19 19:46 UTC2019-07A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORALAB2000-01-28ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-286a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-281c564ffb4f44…
2023-12-20 04:57 UTC2023-12A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-28ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-28a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-289b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-28a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-283f0d92c62455…
2023-05-13 08:27 UTC2023-05A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-28053a50430f4f…
2023-01-26 05:58 UTC2023-01A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORAL2000-01-283bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORALAB2000-01-283a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORALAB2000-01-28f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORALAB2000-01-28e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A075640-001HYDROCHLOROTHIAZIDE12.5MGCAPSULE / ORALAB2000-01-28cb3db0bc1861…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A075640-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A075640-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A075640-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A075640-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A075640-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A075640-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A075640-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03A075640-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A075640-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A075640-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A075640-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A075640-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A075640-001AB1ea99ee380514…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A075640-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A075640-001AB1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A075640-001AB1e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A075640-001AB1cb3db0bc1861…

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51079-776-01EA - Each51079-7764a3bd6d0-1261-47f4-b048-9837889c334212012-07-24
51079-776-20EA - Each51079-77624cecdf7-0352-4c90-9f4f-19f65796d0dc12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
HYDROCHLOROTHIAZIDEACTIVE INGREDIENT0J48LPH2THHYDROCHLOROTHIAZIDE CAPSULE [CARDINAL HEALTH]5
HYDROCHLOROTHIAZIDEACTIVE MOIETY0J48LPH2THHYDROCHLOROTHIAZIDE CAPSULE [CARDINAL HEALTH]5
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UHYDROCHLOROTHIAZIDE CAPSULE [CARDINAL HEALTH]5
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GHYDROCHLOROTHIAZIDE CAPSULE [CARDINAL HEALTH]5
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDHYDROCHLOROTHIAZIDE CAPSULE [CARDINAL HEALTH]5
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKHYDROCHLOROTHIAZIDE CAPSULE [CARDINAL HEALTH]5
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOAHYDROCHLOROTHIAZIDE CAPSULE [CARDINAL HEALTH]5
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357HYDROCHLOROTHIAZIDE CAPSULE [CARDINAL HEALTH]5
GELATININACTIVE INGREDIENT2G86QN327LHYDROCHLOROTHIAZIDE CAPSULE [CARDINAL HEALTH]5
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30HYDROCHLOROTHIAZIDE CAPSULE [CARDINAL HEALTH]5
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3HYDROCHLOROTHIAZIDE CAPSULE [CARDINAL HEALTH]5
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4HYDROCHLOROTHIAZIDE CAPSULE [CARDINAL HEALTH]5
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JHYDROCHLOROTHIAZIDE CAPSULE [CARDINAL HEALTH]5
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJHYDROCHLOROTHIAZIDE CAPSULE [CARDINAL HEALTH]5
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPHYDROCHLOROTHIAZIDE CAPSULE [CARDINAL HEALTH]5
HYDROCHLOROTHIAZIDEACTIVE INGREDIENT0J48LPH2THHYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
HYDROCHLOROTHIAZIDEACTIVE MOIETY0J48LPH2THHYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UHYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GHYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDHYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKHYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOAHYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
GELATININACTIVE INGREDIENT2G86QN327LHYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
SHELLACINACTIVE INGREDIENT46N107B71OHYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JHYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJHYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPHYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
51079-776-2051079077620100 BLISTER PACK in 1 CARTON (51079-776-20) > 1 CAPSULE in 1 BLISTER PACK (51079-776-01) 100 blister pack2005-11-012021-06-30NoNoCurrent